🔗 Share this article

Chancellor Rachel Reeves has announced she is preparing "targeted action to tackle household expense issues" in next month's financial statement.

During an interview with the BBC, she stated that lowering price rises is a collective task of both the government and the central bank.

The UK's inflation rate is expected to be the most elevated among the G7 advanced economies this year and the following year.

Possible Energy Cost Interventions

Reports indicate the government could take action to lower utility costs, for instance by slashing the present 5% level of value-added tax applied on energy.

Another approach is to lower some of the government charges currently included in bills.

Budgetary Constraints and Analyst Predictions

The government will obtain the latest draft from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much scope there is for these actions.

The expectation from most analysts is that Reeves will have to introduce higher taxes or expenditure reductions in order to adhere to her declared borrowing rules.

Earlier on the same day, estimates showed there was a £22 billion shortfall for the Treasury chief to resolve, which is at the more modest range of forecasts.

"There's a shared job between the Bank of England and the government to continue tackling some of the drivers of price increases," Reeves told reporters in the US capital, at the conferences of the International Monetary Fund and global financial institution.

Tax Pledges and International Issues

While a great deal of the focus has been on likely tax rises, the chancellor said the most recent data from the fiscal watchdog had not changed her commitment to manifesto promises not to raise tax levels on income tax, sales tax or National Insurance.

She blamed an "unpredictable world" with increasing geopolitical and trade concerns for the fiscal tax moves, likely to be directed on those "with the broadest shoulders."

International Economic Disputes

Commenting on apprehensions about the United Kingdom's trade ties with the Asian nation she said: "The UK's security interests always come first."

Recent statement by China to tighten export controls on critical minerals and other materials that are key for advanced tech production led American leader Donald Trump to suggest an further 100% import tax on imports from the Asian country, increasing the possibility of an all-out commercial conflict between the two economic giants.

The US Treasury Secretary described the Chinese move "commercial pressure" and "a international production power grab."

Asked about considering the American proposal to participate in its conflict with China, the Chancellor said she was "very concerned" by China's measures and called on the Beijing authorities "not to put up barriers and limit trade."

She said the decision was "bad for the global economy and creates additional headwinds."

"I believe there are fields where we should challenge Chinese policies, but there are also significant chances to sell into Chinese markets, including banking sector and other sectors of the economy. We've got to get that equilibrium appropriate."

The Treasury chief also stated she was collaborating with international partners "on our own critical minerals approach, so that we are more independent."

Health Service Drug Pricing and Funding

Reeves also admitted that the price the NHS spends on medicines could increase as a consequence of current talks with the US government and its drugs companies, in return for reduced taxes and investment.

Some of the world's largest drug companies have said recently that they are either halting or abandoning investments in the United Kingdom, with several attributing the modest returns they are receiving.

Last month, the government science advisor said the cost the NHS spends on drugs would need to go up to stop businesses and pharmaceutical investment departing from the UK.

The Chancellor informed media: "It has been observed as a result of the pricing regime, that clinical trials, new drugs have not been provided in the UK in the manner that they are in other EU nations."

"Our aim is to ensure that patients receiving care from the NHS are able to access the top essential drugs in the globe. And so we are reviewing all of that, and... looking to secure more funding into Britain."